​

GT Biopharma Ownership | Who Owns GT Biopharma?

OverviewForecastFinancialsChart

GT Biopharma Ownership Summary

GT Biopharma is owned by 4.25% institutional investors, 27.57% insiders, and 68.18% retail investors. Farther finance advisors is the largest institutional shareholder, holding 0% of GTBP shares. Fidelity Extended Market Index is the top mutual fund, with 0.39% of its assets in GT Biopharma shares.

GTBP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGT Biopharma4.25%27.57%68.18%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Farther finance advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Farther finance advisors---

Top Buyers

HolderShares% AssetsChange
Farther finance advisors---6.00

Top Sellers

HolderShares% AssetsChange
Farther finance advisors---6.00

Sold Out

HolderChange
Farther finance advisors-6.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252011.11%99,688-91.98%40.10%5-28.57%5150.00%
Dec 31, 20241820.00%1,242,247-0.30%652.11%7133.33%2-33.33%
Sep 30, 202415-6.25%1,246,00715.35%551.40%3-25.00%3-50.00%
Jun 30, 202416-5.88%1,080,160-7.61%630.88%4-6-53.85%
Mar 31, 20241-96.43%1-100.00%----100.00%1-75.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index12.81K0.39%-
Vanguard Institutional Extnd Mkt Idx Tr10.50K0.32%-
Spartan Extended Market Index Pool E4.50K0.20%4.26K
Spartan Extended Market Index Pool F4.62K0.14%-
Fidelity Series Total Market Index3.79K0.12%-470.00
Dimensional US Core Equity USD Acc2.20K0.10%-
Fidelity Total Market Index2.20K0.07%-
BlackRock Extended Equity Market K1.16K0.05%-
Dimensional US Sustainability Core 1 ETF1.64K0.05%-
DFA US Sustainability Core 1799.000.04%-

Recent Insider Transactions

DateNameRoleActivityValue
Apr 11, 2023Breen Michael Martin Executive Chairman/Interim CEOBuy$25.00K
Apr 06, 2023Ohri Manu CFO & SecretaryBuy$25.00K
Dec 22, 2020Wendel Bruce-Buy$12.19K
Nov 16, 2020Wendel Bruce-Buy$10.26K
Dec 22, 2020Wendel Bruce-Buy$3.85K

Insider Transactions Trends

DateBuySell
2023 Q22-
2023 Q1--
2022 Q3--
2022 Q2--
2022 Q1--

GTBP Ownership FAQ

Who Owns GT Biopharma?

GT Biopharma shareholders are primarily institutional investors at 4.25%, followed by 27.57% insiders and 68.18% retail investors. The average institutional ownership in GT Biopharma's industry, Biotech Stocks , is 64.05%, which GT Biopharma falls below.

Does Blackrock own GT Biopharma?

BlackRock is not among the top 10 institutional shareholders of GT Biopharma.

Who is GT Biopharma’s biggest shareholder by percentage of total assets invested?

Farther finance advisors is GT Biopharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 GT Biopharma shares, valued at 0$.

Who is the top mutual fund holder of GT Biopharma shares?

Fidelity Extended Market Index is the top mutual fund holder of GT Biopharma shares, with 0.39% of its total shares outstanding invested in 12.81K GT Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools